BOSNALIJEK / ABOUT US
Leading Pharmaceutical Company in Bosnia and Herzegovina
We are dedicated to the development of preventive action, palliation and cures and to improving the quality of life.
READ MORE
QUALITY, SAFETY AND EFFICACY
Continuously committed to the needs of our customers
We are committed to the continuous and consistent application of quality standards in all aspects of our business operations and processes.
READ MORE
CAREER / EDUCATION AND DEVELOPMENT
Our employees make our business successful
We devote special attention to talent management, career development and succession planning for key organisational positions.
READ MORE
BOSNALIJEK / SOS CHILDREN’S VILLAGES
We invest in our children’s healthy and carefree living
The second generation of children is being raised in an SOS children’s village family supported by Bosnalijek.
READ MORE
Products
We are continuously committed to our customers and pay special attention to monitoring and analysing their needs
MORE
Investors
We are committed to meeting the expectations of our customers, shareholders and employees
MORE
Products
We are continuously committed to our customers and pay special attention to monitoring and analysing their needs
MORE
Career
Join our family and make your contribution to improving the health of people around the world
MORE
PRESS CENTRE / CORPORATE MOVIE
Bosnalijek is a proof that the bravest visions live
In its decades-long business, Bosnalijek has been committed to consistently applying quality in all business operations and processes. Therefore, it produces top quality medicines and ranks among internationally competitive pharmaceutical companies.

The quality system of Bosnalijek is fully compliant with national and international legal regulations and Good Manufacturing Practice standards, which justifies the expectations of users, partners and regulatory bodies.
PRESS CENTRE / NEWS
A successful year for Bosnalijek, revenue up by 10 percent
Last year was very successful for Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina. In 2018, Bosnalijek had a significant increase of revenue and profit continuing a positive trend from the previous several years.
In detail
PRESS CENTRE / VISIT
Third Generation of American Yale University Students Visits Bosnalijek
First and second-year MBA students from the prestigious American University of Yale visited Bosnalijek today, 13 March 2019, as part of their study visit to the Balkans countries.
In detail
PRESS CENTRE / NEWS
Bosnalijek for the 21st Century

On Wednesday 28 March, Bosnalijek d.d. (Bosnalijek), the leading pharmaceutical company in Bosnia and Herzegovina, inaugurated a new Quality Control facility in Sarajevo.
In detail
april 20. 2019 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%